Clinical Trial Update: PROSPECT - Profiling of Resistance Patterns & Oncogenic Signaling Pathways in Evaluation of Cancers of the Thorax and Therapeutic Target Identification

View source ↗

Summary

PROSPECT is profiling resistance patterns and oncogenic signaling pathways in thoracic cancers, including lung cancer, to identify potential therapeutic targets…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Thoracic Cancer

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Lung Cancer, Cancer of Thorax | Status: RECRUITING